GLP-1 has proven benefits outside of weight loss; healthy hums, healthy brain; off-the-shelf cell therapy fights breast cancer – Morning Medical Update

A new analysis of the landmark SELECT trial, published in The Lancet, confirms that semaglutide reduces the risk of major cardiovascular events in people with obesity and preexisting heart disease — even in those without diabetes and…